Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
120
NCT00358046
Efficacy and Tolerability of ILY101 in Dialysis Patients With Hyperphosphatemia
Phase: Phase 2
Role: Lead Sponsor
Start: Jun 30, 2006
Completion: Not specified